Fresenius Kabi

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies. Established in 1999, it focuses on infusion therapy, clinical nutrition, and transfusion technology, making it a leader in these areas across Europe and beyond. The company offers a wide range of products designed for hospitals and home care patients. Its core areas include infusion therapy, which provides intravenous generic drugs and medical devices; clinical nutrition, supplying essential nutrients for patients unable to eat normally; and transfusion technology, offering systems for blood collection and processing. Fresenius Kabi serves hospitals, healthcare professionals, and patients in need of critical care therapies, operating in over 160 countries with a workforce of more than 32,000 employees. Fresenius Kabi has expanded its capabilities through strategic acquisitions and entered the biosimilars market, focusing on treatments for autoimmune diseases and oncology. Its commitment to safe and effective therapies aligns with the broader mission of the Fresenius Group, dedicated to advancing medicine and human health.